Biotech

All Articles

Fierce Biotech Editor-in-Chief Ayla Ellison Speaks Shop with Michelle Benz on the Future of Biotech.

.Let's study a conversation along with Ayla Ellison, Strong Biotech Editor-in-Chief as well as Miche...

New data demonstrate how Bayer's asundexian failed to stop strokes

.Bayer suspended the phase 3 trial for its own variable XIa inhibitor asundexian late in 2013 after ...

Sanofi's tolebrutinib stops working 2 of 3 late-stage MS tests

.Sanofi is still set on taking its own a number of sclerosis (MS) med tolebrutinib to the FDA, execs...

Galapagos' stockpile as fund reveals intent to form its own progression

.Galapagos is actually coming under additional stress coming from entrepreneurs. Having actually cre...

Cell- focused Sana scoops initial CSO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of significant leadership hirings, shootings ...

Allist pays Jacobio $21M, landing job in Mandarin KRAS nationality

.Shanghai Allist Pharmaceuticals has purchased on its own a starring role in China's KRAS market, pa...

ReNeuron leaving behind intention swap after missing fundraising goal

.ReNeuron has participated in the lengthy listing of biotechs to leave Greater london's AIM stock ma...

MBX apply for IPO to take opposition to Ascendis right into stage 3

.MBX Biosciences has added to the current flurry of IPO filings. The biotech, which submitted its do...

FDA broadens probing into Lykos' MDMA tests: WSJ

.For Lykos Therapies and the provider's would-be MDMA-assisted therapy for trauma (POST-TRAUMATIC ST...

Gene editor Tome laying off 131 employees

.Only times after genetics publisher Volume Biosciences revealed confidential operational slices, a ...